Karim Dabbagh
Chief Executive Officer, Board Member at Dualitas Therapeutics
South San Francisco, California, United States
Find your path to Karim
506 people in our graph share verified history with Karim — schools, employers, funds. One of them is your warm intro.
Paul KwanunlockedKarim: together at Stanford University (1999–2001)
×9Karim: together at Stanford University
×2Karim: together at Université Claude Bernard Lyon 1
Chief Executive Officer, Board Member at Dualitas Therapeutics
Intro paths
→
In turn, Karim can intro founders to Dualitas Therapeutics's investors below.
Dualitas Therapeutics's investors · 7
AlexandriaPasadena · since 2025Dementia Discovery FundLondon · since 2025Qiming HealthcareBellevue · since 2025Qiming Venture PartnersBeijing · $5M – $134M checks · since 2025Qiming Venture Partners USACambridge · since 2025SV Health InvestorsBoston · $1M – $20M checks · since 2025Versant VenturesSan Francisco · $250K – $5M checks · since 2025
Experience
- Dualitas TherapeuticsChief Executive Officer/Board membercurrent2026 — presentSan Francisco Bay Area
- GeneviveExecutive Chairman/ Co-foundercurrent2023 — presentSan Francisco Bay Area
- Silver Creek PharmaceuticalsPresident/CEO/Board member2024 — 2026San Francisco Bay Area
- MaaT PharmaChairman of the Board of Directors2023 — 2025
- Second Genome Inc.President and CEO2018 — 2023South San Francisco
- Second Genome Inc.Chief Scientific Officer2014 — 2020San Francisco Bay Area
- PfizerVice President and Head External R&D Innovation and Head Immunology/Immune regulation Department2010 — 2014Cambridge, MA
- ModusBiomedicineCo-founder and CEO2009 — 2010San Francisco Bay Area
- Roche PharmaceuticalsHead of Inflammation Pharmacology2001 — 2009
Skills & more
Biotechnology40Immunology34Life Sciences18Drug Discovery17Drug Development15Pharmaceutical Industry19Biochemistry9Pharmacology11R&D22Clinical Development20Strategy9Business Development3
+8 more
BiopharmaceuticalsMolecular BiologyStart-upsMedical DevicesAntibodiesScienceOncologyLeadershipFrom Karim's professional profile.
Frequently asked questions
- Who is Karim Dabbagh?
- Chief Executive Officer, Board Member at Dualitas Therapeutics
- Where does Karim Dabbagh work?
- Karim Dabbagh is Chief Executive Officer, Board Member at Dualitas Therapeutics.
- Where did Karim Dabbagh go to school?
- Karim Dabbagh studied at Stanford University (Research Fellow, Immunology); Imperial College of Science, Technology and Medicine (BSc (Hons), Biotecnology); University of Califonia, San Francisco (Postdoctoral Fellow, Physiology).
Same school
Also attended Stanford University2,000
Peter ThielCo-founder & Partner at Founders FundDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia CapitalJim BreyerFounder & CEO of Breyer CapitalMike Maples JrCo-founding Partner at Floodgate
+ 1,994 more
Also attended UCL706
Demis HassabisCo-founder & CEO of Google DeepMindAndré DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at Northzone
+ 700 more
Also attended Université Claude Bernard Lyon 134
Anne-Sophie Saint-MartinPartner at Newfund CapitalConstant BeroulleAssociate at Newfund CapitalAlex GerbaudInvestment Director at InnovacomTom BeauvironnetInvestment Manager at KaristaThierry ChignonManaging Partner at Mérieux Equity PartnersAlexia PerouseManaging Partner and CEO at iBionext
+ 28 more
